Ming Yan, CHIEF TECHNOLOGY OFFICER at Cytek Biosciences, Inc. (CTKB), sold 40,000 shares at $6.77 ($270K) on 2024-03-18, disclosed to the SEC on 2024-03-19.
Scheduled sale ($270k) by CHIEF TECHNOLOGY OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.77 | 20,000 | $135K | 50.2% |
| 2 | $6.71 | 20,000 | $134K | 49.8% |
| Total | $6.74 avg | 40,000 | $270K | 100% |
| Filing → |
| CTKB | SELL | 2023-12-21 | $189K | — | Filing → |
| CTKB | SELL | 2023-11-21 | $121K | — | Filing → |
| CTKB | SELL | 2023-10-23 | $96K | — | Filing → |